Moreover, in HT-29 colon cancer cells, quercetin–resveratrol combination treatment reduced the proteins SP1, SP3, and SP4, transcription factors known to be overexpressed in colon cancer. This evidence concerns the gene SP3 and malignant colon neoplasm.